1437 related articles for article (PubMed ID: 24689092)
21. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?
Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T
Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of intestinal metaplasia and mucin staining at the cardia and esophagogastric junction in 225 symptomatic patients presenting for diagnostic open-access gastroscopy.
Byrne JP; Bhatnagar S; Hamid B; Armstrong GR; Attwood SE
Am J Gastroenterol; 1999 Jan; 94(1):98-103. PubMed ID: 9934738
[TBL] [Abstract][Full Text] [Related]
23. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens.
El-Zimaity HM; Graham DY
Am J Gastroenterol; 2001 May; 96(5):1378-82. PubMed ID: 11374671
[TBL] [Abstract][Full Text] [Related]
24. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
25. The gene expression profile of cardia intestinal metaplasia is similar to that of Barrett's esophagus, not gastric intestinal metaplasia.
Oh DS; DeMeester SR; Tanaka K; Marjoram P; Kuramochi H; Vallbohmer D; Danenberg K; Chandrasoma PT; DeMeester TR; Hagen JA
Dis Esophagus; 2011 Sep; 24(7):516-22. PubMed ID: 21309924
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of Barrett's esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux.
Csendes A; Smok G; Burdiles P; Quesada F; Huertas C; Rojas J; Korn O
Dis Esophagus; 2000; 13(1):5-11. PubMed ID: 11005324
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in Barrett's esophagus: short-segment Barrett's esophagus and cardia intestinal metaplasia.
Sharma P
Semin Gastrointest Dis; 1999 Jul; 10(3):93-102. PubMed ID: 10435696
[TBL] [Abstract][Full Text] [Related]
28. Correlation between intestinal metaplasia of the gastric cardia and gastroesophageal reflux disease.
Lanzafame S; Torrisi A; Favara C; Russo V; Emmanuele C
Hepatogastroenterology; 2001; 48(40):1007-10. PubMed ID: 11490786
[TBL] [Abstract][Full Text] [Related]
29. Etiology of intestinal metaplasia at the gastroesophageal junction.
Balaji NS; DeMeester SR; Wickramasinghe KS; Hagen JA; Peters JH; DeMeester TR
Surg Endosc; 2003 Jan; 17(1):43-8. PubMed ID: 12364989
[TBL] [Abstract][Full Text] [Related]
30. [Cytokeratin immunoreactivity patterns in the diagnosis of Barrett's esophagus].
Wang R; Xie J; Shen Y; Ren T
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1820-3. PubMed ID: 23268419
[TBL] [Abstract][Full Text] [Related]
31. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus.
Vaezi MF; Falk GW; Peek RM; Vicari JJ; Goldblum JR; Perez-Perez GI; Rice TW; Blaser MJ; Richter JE
Am J Gastroenterol; 2000 Sep; 95(9):2206-11. PubMed ID: 11007219
[TBL] [Abstract][Full Text] [Related]
32. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients.
Schilling D; Spiethoff A; Rosenbaum A; Hartmann D; Eickhoff A; Jakobs R; Weickert U; Rebe M; Bohrer MH; Riemann JF
Pathol Res Pract; 2005; 200(11-12):801-5. PubMed ID: 15792123
[TBL] [Abstract][Full Text] [Related]
33. Role of Helicobacter pylori cagA(+) strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia.
Peek RM; Vaezi MF; Falk GW; Goldblum JR; Perez-Perez GI; Richter JE; Blaser MJ
Int J Cancer; 1999 Aug; 82(4):520-4. PubMed ID: 10404065
[TBL] [Abstract][Full Text] [Related]
34. Intestinal metaplasia at the gastroesophageal junction: Barrett's, bacteria, and biomarkers.
Morales CP; Spechler SJ
Am J Gastroenterol; 2003 Apr; 98(4):759-62. PubMed ID: 12738452
[TBL] [Abstract][Full Text] [Related]
35. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
36. Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms.
Toruner M; Soykan I; Ensari A; Kuzu I; Yurdaydin C; Ozden A
J Gastroenterol Hepatol; 2004 May; 19(5):535-40. PubMed ID: 15086597
[TBL] [Abstract][Full Text] [Related]
37. Barrett's esophagus and the presence of Helicobacter pylori.
Henihan RD; Stuart RC; Nolan N; Gorey TF; Hennessy TP; O'Morain CA
Am J Gastroenterol; 1998 Apr; 93(4):542-6. PubMed ID: 9576445
[TBL] [Abstract][Full Text] [Related]
38. Reflux esophagitis or Helicobacter infection? - diagnostic value of the inflammatory pattern in metaplastic mucosa at the squamocolumnar junction.
Guenther T; Hackelsberger A; Kuester D; Malfertheiner P; Roessner A
Pathol Res Pract; 2007; 203(12):831-7. PubMed ID: 17993370
[TBL] [Abstract][Full Text] [Related]
39. Two distinct types of cancer of different origin may be mixed in gastroesophageal junction adenocarcinomas in Japan: evidence from direct evaluation of gastric acid secretion.
Horii T; Koike T; Abe Y; Kikuchi R; Unakami H; Iijima K; Imatani A; Ohara S; Shimosegawa T
Scand J Gastroenterol; 2011 Jun; 46(6):710-9. PubMed ID: 21446884
[TBL] [Abstract][Full Text] [Related]
40. Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia.
Liu GS; Gong J; Cheng P; Zhang J; Chang Y; Qiang L
World J Gastroenterol; 2005 Oct; 11(40):6360-5. PubMed ID: 16419166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
